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Abstract
Background: Using microarrays by co-hybridizing two samples labeled with different dyes enables
differential gene expression measurements and comparisons across slides while controlling for
within-slide variability. Typically one dye produces weaker signal intensities than the other often
causing signals to be undetectable. In addition, undetectable spots represent a large problem for
two-color microarray designs and most arrays contain at least 40% undetectable spots even when
labeled with reference samples such as Stratagene's Universal Reference RNAs™.
Results: We introduce a novel universal reference sample that produces strong signal for all spots
on the array, increasing the average fraction of detectable spots to 97%. Maximizing detectable
spots on the reference image channel also decreases the variability of microarray data allowing for
reliable detection of smaller differential gene expression changes. The reference sample is derived
from sequence contained in the parental EST clone vector pT7T3D-Pac and is called vector RNA
(vRNA). We show that vRNA can also be used for quality control of microarray printing and PCR
product quality, detection of hybridization anomalies, and simplification of spot finding and
segmentation tasks. This reference sample can be made inexpensively in large quantities as a
renewable resource that is consistent across experiments.
Conclusion: Results of this study show that vRNA provides a useful universal reference that yields
high signal for almost all spots on a microarray, reduces variation and allows for comparisons
between experiments and laboratories. Further, it can be used for quality control of microarray
printing and PCR product quality, detection of hybridization anomalies, and simplification of spot
finding and segmentation tasks. This type of reference allows for detection of small changes in
differential expression while reference designs in general allow for large-scale multivariate
experimental designs. vRNA in combination with reference designs enable systems biology
microarray experiments of small physiologically relevant changes.
Background
Microarray results enable systems biology only to the
extent that they have (1) sensitivity/repeatability to detect
low physiological-range regulatory events, (2) global
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detectability of spots to reveal broad system behavior, and
(3) flexibility to support multivariate experimental
designs. The present paper reports a new technical
approach that improves microarray performance in all
three of these areas. Due to variations in geometry,
amount of DNA, hybridization efficiency, and back-
ground fluorescence at each spot, absolute fluorescence is
not a reliable measure of mRNA abundance. However, if
two samples are labeled with different dyes and co-
hybridized to the same microarray, the ratio of their fluo-
rescence intensities is a reliable measure of the differential
RNA abundances between the samples. There are three
typical designs used in two-color microarray experiments:
dye swap, loop, and reference designs [1] and their advan-
tages and disadvantages have been discussed in previous
literature [2-4]. Loop and dye swap designs are useful for
small studies (less than 5–10 samples) because they
reduce variance and make full use of hybridization
resources [2]. For larger studies, reference designs enable
flexibility of (1) comparing all samples to each other
through a single reference sample (2) expanding the
design if more samples are needed (3) handling multivar-
iate experimental designs such as time series or classifica-
tion of multiple conditions [5,6]. Also, dye bias ((1)
intensity dependant and (2) gene specific) is less of an
issue in a reference design because (1) the dye incorpora-
tion effects cancel out in across array calculations in a
manner similar to dye swap calculations and (2) gene-dye
interactions are not an issue because the sample of interest
is only measured on one dye. The reference design has
been used successfully in a number of large microarray
experiments [7-9].
An ideal reference RNA should (1) provide strong signal
intensity to every probe on the microarray (2) be reliably
reproducible in large batches (3) allow for comparison of
datasets across laboratories and (4) mimic the hybridiza-
tion characteristics of the biological sample it is compared
against. Researchers typically prepare their own reference
from pooled experimental samples or cell lines [7-10].
However these approaches are not easily reliably repro-
ducible between labs and provide detectable signal for
only 60–70% of the spots on a typical genomic-scale
array. A reference sample derived from a mixture of cell
lines is commercially produced by Stratagene called Uni-
versal Reference RNA™ (Stratagene, La Jolla, CA) and is a
commonly used reference RNA but still only yields detect-
able signal for 60–70% of the spots on most microarrays
[11]. Other groups have used genomic DNA [12,13], a
mixture of clones spotted on the arrays [14,15], and a
short oligomer that is complementary to every spot on the
microarray [16]. However, a mixture of clones is specific
to array design and thus is generally not usable between
laboratories and short oligos do not have the same
hybridization characteristics as longer RNA molecules in
biological samples [17]. While a genomic DNA reference
does mimic cDNA hybridization characteristics, it repre-
sents a heterogeneous sequence distribution and requires
a different reference for each species. None of these three
methods are widely used and publicly available data is not
widely available. Therefore we focus our comparison with
Stratagene Universal Reference.
In the present approach, we describe a universal RNA ref-
erence that possesses features 1–4 discussed above. This
universal reference RNA contains a sequence from the vec-
tor that is common to all of the cDNA spotted on the
slides but does not contain any specific gene sequence. We
call this reference sample "vector RNA" (vRNA) and its use
in a reference design "vector reference design". Using
vRNA provides strong signal for every spot on a microar-
ray. This allows for within-slide quality control of printing
errors, large hybridization inefficiencies and within-batch
quality control of insufficient concentrations of spotted
DNA on a per spot basis. Finally, use of vRNA as a refer-
ence assists in spot finding because every spot has a detect-
able signal.
Results
Development of vRNA sample
We obtain a homogeneous RNA sample from the parental
EST clone vector as described in Methods and outlined in
Figure 1. This reference RNA (vRNA) contains a 220 base
pair sequence from the vector that is common to all of the
cDNA spotted on the slides, but does not contain any spe-
cific gene sequence. Oligomers larger than 60 bases have
similar hybridization characteristics as biological RNA
[17]. vRNA was tested on 40 microarrays and was found
to reproducibly yield strong signal for almost every spot
on the array.
Detectability
We call a spot detectable if it has a signal-to-noise ratio
(SNR) larger than three (see Methods) and define percent
detectability as the fraction of all spots on an array that are
detectable. For comparison to other results [11], we also
calculate percent spots with a signal to background ratio
(SBR) greater than two. We studied cDNA and oligonucle-
otide microarray datasets in the Gene Expression Omni-
bus (GEO) [18] that used StrataGene's Universal
Reference RNA™. A search on GEO of "Stratagene Univer-
sal Reference" yields 44 experiments (as of October 31,
2005). The subset of these that contain background signal
standard deviation information were analyzed for signal
detectability using SNR and signal-to-background ratio
(SBR). The results are presented in Table 1 (rows 1
through 20). On average in these datasets, only 60% of
the genes had detectable spots (range was 14% to 87%
detectable spots, see Table 1). vRNA empirically is cali-
brated such that almost all spots are detectable (see Meth-BMC Genomics 2006, 7:109 http://www.biomedcentral.com/1471-2164/7/109
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ods). Table 1 shows that the vRNA dataset has 97%
detectable spots on the vRNA channel (Cyanine-3; Cy3).
Typically additive background noise corrupts the meas-
urements of one dye more than the other affecting the
detectability of the signal [19,20]. Therefore, using vRNA
with the weaker dye can greatly increase the overall
detectability of spots.
Calibration of vRNA sample
We performed a titration experiment using concentrations
1:25, 1:50, 1:100, and 1:200 of vcDNA prepared (as
described in Methods). Ideally, signal intensities for all
spots should decrease 50% with each dilution. A ratio of
less than two suggests either saturation or loss of detecta-
bility, and thus the best dilution is the one that yields the
highest signal intensity in the linear regime of the dilution
curve. Figure 2 illustrates the intensities of low, medium,
and high intensity spots over different vcDNA dilutions.
The dilution that was the best for the majority of the spots
was 1:50.
Narrow dynamic range of vRNA signal intensity
We compared the dynamic range of datasets using Strata-
gene Universal Reference RNA™ as reference to our vector
reference design with respect to the metric of detectability
without saturation. The spot intensities obtained from
GEO datasets (Table 1) using Stratagene's Universal Refer-
ence RNA™ ranges from undetectable to saturation. How-
ever, spot intensities of vRNA are more consistent, never
saturated, and undetectable only when the concentration
of spotted PCR product is insufficient. Figure 3 shows his-
tograms of background corrected spot intensities of
microarray experiments representative of using Strata-
gene's Universal Reference RNA™ (from dataset GSE1706;
this dataset is typical, other datasets shown in Supplemen-
tary Figure 1) and vRNA. We also expect the dynamic
range of vRNA signal intensity to be smaller than that of
genomic DNA reference because vRNA is homogenous.
vRNA allows for more flexibility in calibration than a bio-
logically derived reference because the vcDNA is homoge-
neous and the resulting signal intensities have a smaller
dynamic range.
Comparison of reference designs using biologically derived 
reference and vRNA
Stratagene's Universal Reference RNA™ (Stratagene, La
Jolla, CA) is a commonly used biologically derived refer-
ence for use in reference designs [5]. We studied cDNA
and oligonucleotide microarray datasets in GEO that used
StrataGene's Universal Reference RNA™. All 20 datasets in
Table 1 showed a statistically significant difference in
detectability between dyes. Most groups show improved
Table 1: Signal to noise ratio (SNR) and signal to background ratio (SBR) detectability metrics microarray datasets. The first 20 
microarray datasets use Stratagene Universal Reference RNA™ as a reference. The bottom 2 microarray datasets are datasets 
generated by our laboratory
SNR > 3 SBR > 2
Experiment Platform Cy3 Cy5 Both Cy3 Cy5 Both Pubmed ID
GSE332 GPL260 89% 88% 87% 68% 67% 64%
GSE333 GPL260 89% 80% 80% 66% 49% 47%
GSE432 GPL285 55% 24% 24% 42% 25% 24%
GSE1041 GPL981 65% 48% 47% 75% 68% 66%
GSE1138 GPL977 58% 48% 42% 82% 72% 69% 15156144
GSE1319 GPL1197 91% 83% 83% 86% 88% 84% 15328174
GSE1486 GPL1225 33% 27% 19% 18% 37% 16%
GSE1533 GPL1299 20% 19% 14% 25% 34% 21%
GSE1645 GPL1384 54% 51% 46% 63% 63% 58% 15718295
GSE1705 GPL1390 96% 86% 85% 91% 87% 87%
GSE1705 GPL885 87% 59% 58% 80% 71% 70%
GSE1705 GPL887 71% 61% 59% 67% 79% 65%
GSE1706 GPL1390 88% 75% 74% 81% 83% 77% 15679094
GSE1706 GPL885 88% 78% 76% 75% 79% 72% 15679094
GSE1706 GPL887 76% 54% 53% 71% 56% 56% 15679094
GSE1818 GPL885 100% 100% 100% 100% 97% 97% 15994931
GSE2134 GPL1786 86% 89% 83% 89% 89% 87%
GSE2900 GPL2614 72% 88% 70% 80% 91% 80% 15838786
GSE3023 GPL2695 78% 86% 74% 85% 94% 85% 16168081
GSE3023 GPL2696 82% 86% 81% 88% 89% 87% 16168081
GSE2718 GPL2000 86% 74% 71% 82% 73% 67% 16189278
vRNA in-house 97% 95% 93% 97% 90% 87%BMC Genomics 2006, 7:109 http://www.biomedcentral.com/1471-2164/7/109
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Cy5 signal detectability over Cy3 (range between labora-
tories: 2%–33%, mean difference: 6%, p < 0.0001). In
typical cases where detectability is significantly different
between the dyes, it is clear that vRNA can improve the
detectability of the weaker channel thus boosting the frac-
tion of genes that produce detectable signal. We have cal-
culated detectability measurements for an arbitrary
sample of GEO experiments that use pooled biological
samples as a reference and obtained similar results (data
not shown).
Value of the vector reference design with respect to quality 
control issues
vRNA can be used as a quality control sample. By hybrid-
izing labeled vcDNA with saturating concentrations in
vast excess of the DNA spotted on the slide, all of the spots
containing clones should show spot intensities propor-
tional to the amount of DNA competent for hybridization
in the spot. In the vRNA design those spots that do not
have signal intensities much higher than background (by
simple manual visualization, or by statistical measures
such as SNR) represent clones that have insufficient con-
centrations of PCR product possibly due to failed or inef-
ficient PCR reactions, no bacterial growth, or robotic
printing errors. Rouse et al. describes a reagent derived
from synthesized oligonucleotides similar to vRNA in
order to quantitate the amount of cDNA printed in each
array element and subsequently determine the molar sto-
ichiometry of the target cDNA bound to the probe mole-
cules available for hybridization [21].
In a study of ethanol adaptation using vRNA [22], the
median fraction of detectable spots using vRNA was 86%
(Table 1; GSE2718). About 10% of the spots contained
insufficient concentrations of PCR product and were eas-
ily distinguishable from other spots using a SNR thresh-
old of 3 (Supplementary Figure 2). After rearraying our
slides and adding higher concentration PCR product to
Signal intensity (log2) of high (▲ ), medium (■ ) and low (● )  mRNA abundances vs dilution Figure 2
Signal intensity (log2) of high (▲ ), medium (■ ) and low (● ) 
mRNA abundances vs dilution. 1:25 dilution saturates high 
abundance RNA samples whereas 1:200 dilution results in 
undetectable signal for low abundance RNA. High, medium 
and low mRNA abundances. 1:50 dilution produces detecta-
ble but not saturated signal for the most spots.
Schematic of vRNA production Figure 1
Schematic of vRNA production. (a) The parental EST clone 
vector (pT7T3D-pac) is used as a template for PCR with 
GF200 primers. (b) The PCR product is further amplified and 
converted to aRNA via an in vitro transcription reaction. (c) 
The aRNA is reverse transcribed and incorporated with 
amino allyl dUTP creating vcDNA. (d) The vcDNA is coupled 
with Cy3 dye. (e) The product of eight labeling reactions are 
combined (20 uL) and diluted to 125 uL.
pT7T3D-Pac
GF200F GF200R
T7 MCS
PCR
GF200F Mutiple Cloning Site T7 GF200R
EcoR NotI
Mutiple Cloning Site GF200R
EcoR NotI
Mutiple Cloning Site GF200R
EcoR NotI
Mutiple Cloning Site GF200R
EcoR NotI
IVT
RT
Cy3 Coupling
vRNA
vcDNA
Labeled
vcDNA
A
B
C
D
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spots with low signal intensity from the vRNA sample, the
median Cy5 detectability was increased to 95% and the
Cy3 detectability was increased to 97% (Table 1 – vRNA).
vRNA can identify printing errors. While insufficient PCR
product from printing plates yield undetectable spots on
every slide, some slides contain missing spots specific to
that slide due to a robotic printing error where the print
tip did not touch that microarray and deposit cDNA.
vRNA provides an in-slide control for all printing errors.
The data from spots not printed should not be considered
in subsequent microarray analysis. Figure 4a shows an
example of spots not printed as detected by the vRNA
sample channel.
Finally, the vRNA can help detect hybridization inconsist-
encies by showing non-uniformities in the image. Figure
4b illustrates an artifact caused by an air bubble as seen on
the vRNA sample channel. This anomaly is not visually
obvious in the image of the biological sample channel
(Figure 4c) and, by inference, in the image of a biologi-
cally derived reference sample (Stratagene or pooled bio-
logical samples). The overall uniformity of signal
intensities resulting from using vRNA makes it possible
for researchers to quickly identify and flag these problem
areas of the microarray. As with other reference designs,
the reference channel may help to normalize these anom-
alies from slide to slide, but if the anomaly is visibly clear,
we suggest flagging those spots as bad spots and removing
these features from downstream analyses.
vRNA and spot finding
Using vRNA yields a bright signal for each spot (barring
issues described in the quality control section) and there-
fore makes spot finding much simpler. By thresholding
the image by some large pixel intensity that is well above
the background intensity level but within the range of the
vRNA signal (around 2000 in our experience), all contig-
uous objects with over 50 pixels represent a spot or a
bright artifact (Figure 4). The spots are uniformly distrib-
uted with a grid pattern (within tolerance of small print-
ing variability) and because over 90% of the spots should
be bright (even considering array quality control issues),
detecting the subarrays and the positions of each spot is
straightforward. Since the channel representing the vRNA
sample contains the same physical layout as the channel
Histograms of background corrected spot intensities of reference samples Figure 3
Histograms of background corrected spot intensities of reference samples. (a) Stratagene Universal Reference RNA™ from 
dataset GSE1706 (b) vRNA. Note that the range of background corrected spot intensities in a biologically derived reference 
(Stratagene Universal Reference RNA™) cover 11 orders of magnitude and the middle 50% of the spot intensities cover 5 
orders of magnitude whereas background corrected spot intensities using vRNA covers 7 orders of magnitude and middle 50% 
of the spot intensities cover 2 orders of magnitude.BMC Genomics 2006, 7:109 http://www.biomedcentral.com/1471-2164/7/109
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representing the biological sample, the same spot location
and segmentation data derived from the reference channel
can be applied to the biological sample channel.
Discussion
Based on our analysis of publicly available datasets from
GEO, the vector reference design improves on previous
approaches to reference design. The vRNA results show
improved detectability compared to traditional references
such as the Stratagene Universal Reference RNA™ or
pooled biological samples. We measured detectability as
a function of signal-to-noise ratio (SNR) and signal-to-
background ratio (SBR). The second measure (SBR) is not
as statistically rigorous and can be biased by adjusting the
mean background signal up or down, but using it allows
one to also consider datasets which do not include back-
ground intensity standard deviations, which is typical of
most datasets publicly available in GEO (as of October 31,
2005). One dataset (GSE1818; see table 1) was excluded
due to atypical background issues. For all cases evaluated,
vRNA provides higher detectability than the other refer-
ences used.
We showed how vRNA could be used for spot finding and
for quality control of PCR product generation, batch
printing, array manufacture, protocol evaluation, and
individual hybridizations. The vRNA sample channel
image can be visually inspected to ensure that there are no
artifacts caused by technical problems. Spots with low sig-
nal detectability should be flagged as bad spots and
excluded from downstream analyses. Commercial refer-
ences and pooled sample references do not lend them-
selves to these quality control features because they
contain many genes with low expression and thus pro-
duce many spots that are not detectable. Therefore anom-
alies that are apparent using vRNA as a reference are
hidden when using other reference samples.
Reference samples yielding detectable but not saturating
signals for all spots have been previously reported. Several
groups created references from the clones used to make
their microarrays. The first approach, outlined by Dudley
et al [16], uses a 25 mer oligomer that matches a small
portion of the parental EST clone vector that is contained
in every PCR product printed on the microarray. Specifi-
cally, it matched the PCR primer used to make PCR prod-
uct from the clones. However, the melting point of
hybridized oligomers increases with length up to about 60
bases [17]. Therefore, the characteristics of hybridization
to the spotted cDNA are different between a 25 base oli-
gomer and a typical cDNA (~100–1500 bases). Ideally, a
reference should have identical hybridization characteris-
tics to biological cDNA to control for hybridization varia-
bility.
A second method of creating a universal reference from
the characteristics of the clone is described by Sterreburg
et al. [14]. Briefly, they suggest pooling all clones together
in a single tube, performing a PCR reaction to create in
vitro transcription template for all of the cDNA inserts, in
vitro transcription of the PCR product, DNase treatment,
reverse transcription, and labeling. This produces a refer-
ence sample representing all of the sequences on the array.
Each sequence in the reference sample still contains the
flanking regions of the parental EST clone vector. Gorreta
et al. [15] simplifies this process by simply labeling the
Microarray images showing technical errors detected by vRNA Figure 4
Microarray images showing technical errors detected by vRNA. (a) The two subarrays on the right show two rows each that 
were not printed. Additionally there are several weaker spots that indicate less PCR product spotted in those locations. (b) 
Image of vRNA sample channel showing a large area of low signal intensities (a portion enclosed by the white circle) where 
labeled sample did not hybridize well to the slide, possibly due to an air bubble. (c) Image of the biological sample from the 
same microarray. It is not easy to see a hybridization problem on this channel because of the large variation of signal intensities.BMC Genomics 2006, 7:109 http://www.biomedcentral.com/1471-2164/7/109
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PCR product. Both of these reference samples yield over
90% detectability of all spots on the array whereas the
Stratagene Universal Reference RNA™ sample produces
50% detectability [15]. However, reference sample pro-
duced by both of these methods cannot be used to com-
pare datasets across laboratories.
We developed a new universal reference combining and
extending the advantages of Sterrenburg et al. [14], Gor-
reta et al. [15], and Dudley et al. [16] show that only the
sequence common to all of the PCR products (i.e. the
sequence in the parental EST clone vector between the
PCR primers) is needed to provide a strong detectable sig-
nal and reliable measure of hybridization and printing
variability. We have developed a method to make such a
reagent that is quick, cheap, repeatable, and effective.
Rouse et al. uses a similar reagent, in large molar excess to
probe molecules, in a method which attempts to deter-
mine a stoichiometric molar ratio between hybridized
cDNA and available probe molecules spotted on the array
[21]. Our universal reference increases the detectability of
spots on an array to an average of 97%. This is comparable
to their results [14,15] while requiring significantly less
effort and money and providing a homogeneous RNA
sample. Finally, although the concept of using a vRNA ref-
erence is universal, one must ensure the appropriate
parental sequence is used. A commercially produced
vRNA sample would allow for comparison of datasets
across laboratories using cDNA microarrays that use the
same parental vector. pT7T3D-Pac vectors are commonly
used in clone libraries. 50% of all rat clones, 25% of all
mouse clones, and 25% of all human clones use the
pT7T3D-Pac vector.
We have presented a method for creating a vRNA sample
using clones containing the pT7T3D-Pac vector. vRNA can
be made for clones that use other vectors as well. The T7
RNA amplification step requires a T7 promoter, which is
present in many vectors. Alternatively, PCR can be used to
replace the in vitro transcription (IVT) step. Multiple vec-
tors (e.g. pT7T3D-Pac, pSPORT1, and pCMV-SPORT6)
can be mixed together to create a universal reference that
can be used on 75% of all rat, mouse, and human clones.
Vector reference designs can only be used in microarrays
that are spotted with cDNA that have common sequence,
such as PCR product generated from clones. Affymetrix
arrays typically use one dye and are not amenable to ref-
erence designs because they contain short (16–25 mer)
gene specific sequences with no common sequence on all
array features. Spotted oligonucleotide arrays such as
Operon (Operon Biotechnologies, Huntsville, AL) or
Compugen/Sigma (Compugen USA, San Jose, CA; Sigma
Co., St. Louis, MO) do not contain a common sequence
in each spot. In the future, such a 60 base sequence could
be manufactured. Currently 110 bases can be efficiently
synthesized (Sigma). Therefore, a small improvement in
oligonucleotide synthesizing techniques could yield 140
base oligonucleotides that contain 70 bases of a gene of
interest and 70 bases of a common sequence. In situ oligo-
nucleotide arrays such as Agilent arrays could, in princi-
ple, be designed in a similar manner. However, current
commercially available in situ oligonucleotide synthesis
arrays are limited to 60 base oligomers (Agilent Technol-
ogies, Palo Alto, CA).
vRNA reference designs increase reproducibility across
experiments because the reference signal is detectable for
all spots on the array. This increased reproducibility of
data across arrays increases the sensitivity of the differen-
tial gene expression measurements and enables system-
wide detection of small, physiologically relevant changes
in gene expression.
Conclusion
Results of this study show that a reference sample (vRNA)
derived from the parental EST clone vector of all clones
printed on an array provides a useful universal reference
that can be used for quality control of microarray printing
and PCR product quality, detection of hybridization
anomalies, and simplification of spot finding and seg-
mentation tasks. vRNA can be made inexpensively in large
quantities as a renewable resource that is consistent across
experiments. This type of reference allows for detection of
small changes in differential expression while reference
designs in general allow for large-scale multivariate exper-
imental designs. vRNA in combination with reference
designs enable systems biology microarray experiments of
small physiologically relevant changes.
Methods
Universal vector reference generation
The EST clones used to manufacture the cDNA arrays
described herein all used the pT7T3D-Pac vector (gener-
ously provided by the BMAP group at University of Iowa).
Therefore, they all contained the same sequence between
the viral promoters (T3 and T7) and the multicloning site
between the Notl and EcoRI. PCR of an empty vector
using GF200 primers (5'-CTGCAAGGCGATTAAGTT-
GGGTAAC-3' and 5'-GTGAGCGG-ATAACAATT-
TCACACAGGAAACAGC-3') yields a template for T7
based RNA amplification (MessageAmp™ T7 Linear
Amplification Kit, Ambion, Austin, TX) to produce "vector
RNA" (vRNA). vRNA was reverse transcribed (detailed fur-
ther below) with dNTPs, amino allyl-dUTP and random
nanomers and coupled with the monoreactive succinim-
ide ester derivative of a Cy3 or Cy5 dye to create labeled
vector derived cDNA (vcDNA).BMC Genomics 2006, 7:109 http://www.biomedcentral.com/1471-2164/7/109
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RNA sources
RNA sources used to generate datasets obtained from
GEO are described in their respective papers (Table 1).
RNA for the in house dye swap and the reference data were
collected from male Sprague-Dawley rats from Charles
River Laboratories (Wilmington, MA) housed at the Ani-
mal Core Facility of the Thomas Jefferson University. The
animals were sacrificed by rapid decapitation and the
nucleus tractus solitarius (NTS) was isolated by microdis-
section. Total RNA was extracted using Qiagen's RNeasy
mini kit (Qiagen, Valencia, CA), yielding 200–900 ng of
total RNA. RNA quality was assessed using a RT-PCR pro-
tocol for high and low copy number genes (β-actin and
tyrosine hydroxylase respectively). Tyrosine hydroxylase
was selected because it is specific to the NTS at the slice
level and punch region, confirming that the punches con-
tained the NTS.
Microarray manufacture
Microarrays were fabricated using a rat clone set (GF200;
ResGen Huntsville, AL) for cDNA microarrays consisting
of approximately 1900 sequence-verified non-redundant
cDNA clones (as of Unigene build 78) and an additional
6900 clones from Invitrogen (Invitrogen, Carlsbad, CA)
for a total of 8800 clones. cDNA probes from EST clones
were prepared from freshly grown overnight bacterial cul-
tures by PCR amplification using GF200 primers (Invitro-
gen). PCR products were purified and verified by agarose
gel electrophoresis, and the yield was determined spectro-
photometrically (NanoDrop Wilmington, DE). cDNAs
were mixed with equal volume of DMSO (10–70 ng/µl)
and printed onto FMB cDNA slides (Full Moon Biosys-
tems, Sunnyvale, CA) using a MicroGrid II arrayer
(Genomic Solutions, Ann Arbor, MI). Microarrays were
air dried for 30 min and cross-linked by UV irradiation.
We printed arrays of 18,240 spots representing 8832
clones and 288 internal controls in adjacent duplicate
spots.
RNA amplification and labeling
Total RNA (70–400 ng) was amplified using two rounds
of the antisense RNA (aRNA) technique [23], yielding on
average 180 µg aRNA (MessageAmp, Ambion, Austin,
TX). aRNA (1.125 µg) was reverse transcribed (Superscript
II, Invitrogen) using random primers to generate single
stranded amino-allyl derivatized cDNA, which was cou-
pled with Cy dyes (Cy3 or Cy5) to produce fluorescently
labeled cDNA.
Hybridization
Microarrays were prehybridized in 1% bovine serum albu-
min, 5× SSC, 0.1% SDS for 45 min at 42°C, washed in
H2O and dried by centrifugation. Cy3 labeled vDNA and
Cy5 labeled cDNA samples were mixed with 50 µl of Dig
Easy Hybridization buffer (Roche, Indianapolis, IN) con-
taining 25 µg each of yeast tRNA and calf thymus DNA
and applied to the microarrays for hybridization at 37°C
for 16 hours in a hybridization chamber (Corning, Corn-
ing, NY) in the dark with gentle agitation. Slides were
washed for 10 minutes at 50°C in 1× SSC and 0.1% SDS
in shaking incubator, followed by a 1 minute wash in 1×
SSC, three 1 minute washes in 0.1× SSC, and one rinse in
H2O, at room temperature. Slides were dried by centrifu-
gation and scanned with a ScanArray 5000 XL (Perk-
inElmer, Wellesley, MA). Image analysis was performed
using ScanArray Express v2.2 software.
Dilution calibration
In 8 tubes, 8 aliquots of 2 µg of vRNA sample was con-
verted to Cy3 labeled vcDNA as described above. The
labeled reference was pooled (20 µL final volume). Dilu-
tions of 1:25, 1:50, 1:100, and 1:200 of this pooled sam-
ple were combined with water (2.5 µL final volume per
dilution), hybridized to four separate arrays, scanned, and
quantitated.
Data analysis
Spot quantitation from images
We quantitated the scanned images with ScanArray
Express 2.0 using the adaptive thresholding quantitation
algorithm to generate values for median signal intensity,
median background intensity, and background intensity
standard deviation for each spot on the array. In this anal-
ysis, no spots were flagged, but the array data was visually
inspected and arrays with atypical signal were discarded
and redone. For each dataset used from GEO, the spot
quantitation and software and algorithms are discussed in
each dataset's corresponding publication (Table 1).
Detectability metrics
We model measured signal intensity (log-normalized) as
the underlying real signal corrupted by white noise:
measured signal intensity = true signal - N(µb - σb)
Where µb is the mean background intensity and σb is the
standard deviation of the background intensity. We wish
to calculate signal detectability. There are three ways this
is done in the literature. (1) From signal processing [4],
the detectability of a signal can be determined by the sig-
nal-to-noise ratio (SNR)which is:
(2) Another method uses the mean and standard devia-
tions of the mean signal intensities of all negative control
spots as a surrogate for mean and standard deviation of
background intensity of each spot [15]. This method
allows for the possibility of some spot autofluorescence
mean signal intensity mean background intensity
standard de
−
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but does not account for local background effects. (3)
Stratagene and others [11] use the ratio mean signal inten-
sity to mean background intensity (signal-to-background
ratio or SBR). This measure can be biased by adjusting the
offset on the photomultiplier tube, effectively adding or
subtracting a constant to both the signal and background.
However, it may be the only option in analyzing datasets
where standard deviation of background signal is not
given.
Using SNR as defined by [4] as a metric, we consider a
spot detectable if the SNR > 3 (following [4] and signal
processing literature). Using SBR as a metric, we consider
a spot detectable if the SBR > 2, which produces similar
results as SNR > 3 and is used by [11] and Stratagene).
Method (2) is difficult to use on a wide variety of public
microarray datasets because it is often difficult to interpret
the meaning of the controls. Some laboratories call a loca-
tion that was not spotted as empty while others call a loca-
tion with a spot of DMSO as empty. We only calculate the
detectability of spots representing genes of interest and
exclude control spots from this analysis.
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